Related Experiment Video
Updated: Sep 19, 2025
10:17
Real-Time Cardiac Mapping with a Noninvasive Imageless Electrocardiographic Imaging System
Published on: April 11, 2025
967
Should Ivabradine be First-Line Therapy for Inappropriate Sinus Tachycardia?
Asif Khan1, Joanne Ling1, Valay K Parikh1
1Department of Cardiology, Northwell, New Hyde Park, New York, USA.
Pacing and Clinical Electrophysiology : PACE
|June 2, 2025
Summary
Inappropriate sinus tachycardia (IST) is treated with Ivabradine, which targets the funny current (If) channel. This targeted approach offers a safer and more effective first-line therapy for IST patients compared to traditional medications.
Area of Science:
- Cardiology
- Electrophysiology
- Pharmacology
Background:
- Inappropriate sinus tachycardia (IST) is a rare syndrome with persistent resting heart rate >100 bpm.
- IST is linked to dysfunctional funny current (If) channels in the sinoatrial node.
- Current therapies like beta-blockers are often inefficient and poorly tolerated.
Purpose of the Study:
- To review the mechanism of action and efficacy of Ivabradine for IST treatment.
- To support Ivabradine's role as a first-line therapy for IST.
Main Methods:
- Literature review of studies on Ivabradine in IST patients.
- Analysis of Ivabradine's specific mechanism of blocking the If current.
- Evaluation of safety profile and symptomatic improvement.
Main Results:
- Ivabradine effectively lowers basal, mean, and maximal heart rate in IST patients.
- Ivabradine demonstrated a favorable safety profile.
- Symptomatic improvement was observed in patients treated with Ivabradine.
Conclusions:
- Ivabradine's unique If channel blockade offers a targeted IST treatment.
- Ivabradine is a safe and effective first-line therapy for inappropriate sinus tachycardia.
- The drug's mechanism provides superior efficacy at higher heart rates compared to beta-blockers.
Keywords:
dysfunctional funny channelsfunny currentinappropriate sinus tachycardiaivabradinesinus tachycardiaMore Related Videos
Related Concept Videos
01:16ECG Interpretation of Arrhythmias I: Sinus Arrhythmias
425
Arrhythmias are disturbances in the heart's rhythm that lead to abnormal heartbeats. These irregularities can originate from different parts of the heart and are classified based on their origin and nature.
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
Types of Arrhythmias
Sinus Node Arrhythmias
Sinus Bradycardia: Originating from the sinoatrial (SA) node, sinus bradycardia involves slower impulses, resulting in a heart rate of less than 60 beats per minute (bpm). Causes include sleep, vagal stimulation, beta-blockers, hypothyroidism,...
425
01:18Dysrhythmias IV: Characteristics of Bradyarrhythmias
125
Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
125
01:20Antiarrhythmic Drugs: Class IV Agents as Calcium Channel Blockers
1.0K
Class IV antiarrhythmic drugs, such as verapamil and diltiazem, block calcium channels. They primarily affect the heart, slowing the conduction in calcium-dependent tissues like the SA and AV nodes. These drugs manage reentrant supraventricular tachycardia (SVT) and reduce ventricular rate in atrial flutter/fibrillation.
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
Verapamil, a calcium channel blocker, inhibits calcium movement across myocardial cell membranes and vascular smooth muscle. This results in the dilation of coronary and...
1.0K
01:22Antiarrhythmic Drugs: Class I Agents as Sodium Channel Blockers
1.8K
Class I antiarrhythmic drugs are used to treat various types of arrhythmias or irregular heart rhythms. These drugs block the sodium (Na+) channels in the cardiac cells, thereby affecting the movement of electrical impulses across the heart. Class I antiarrhythmic drugs are divided into three subgroups: Class IA, Class IB, and Class IC, each with distinct mechanisms of action and effects on the heart.
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
Class 1A Antiarrhythmic Drugs: These drugs work by moderately blocking sodium channels,...
1.8K
01:24Antiarrhythmic Drugs: Class II Agents as β-Adrenergic Blockers
913
Adrenergic stimulation generally impacts cardiac rate and rhythm. Specifically, stimulation of the β-adrenoceptors triggers an increase in intracellular calcium ion influx and pacemaker currents, which may cause arrhythmias. Catecholamines like adrenaline also demonstrate β2-adrenoceptor-mediated hypokalemia, impacting cardiac action potential and disrupting the normal cardiac rhythm. Class II antiarrhythmic drugs are β-adrenoceptor antagonists or β-blockers, which...
913
01:25ECG Interpretation of Arrhythmias II: Atrial, Junctional and Ventricular Arrhythmias
174
Arrhythmia is a condition characterized by an irregular heart rhythm, with ECG changes that differ based on its origin and nature. The types of arrhythmias discussed below include atrial, junctional, and ventricular arrhythmias.Atrial ArrhythmiasPremature Atrial Complexes (PACs): PACs are early atrial beats caused by stress, caffeine, alcohol, electrolyte imbalances, hypoxia, hyperthyroidism, or certain medications (e.g., bronchodilators and decongestants). The ECG shows early P waves with an...
174